Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2009
  • Online publication date: July 2009

17 - Dementia and cognition in the oldest-old

Summary

Introduction

Fueled by medical and technological advances, average life expectancy in the USA has increased by more than 25 years over the past century. A consequence of increased longevity and the aging of the “baby boomers” is that the oldest-old (age 90 or older) have become the fastest growing segment of the US population. Currently, there are fewer than 2 million Americans aged 90 and older, but this number will increase to approximately 10 million by 2050. In terms of percentage of the population, those aged 90 and older presently represent 0.5% of the population in the USA, while by the middle of the twenty-first century, they will form about 2.5% of the population as depicted in Fig. 17.1. Moreover, the increases in the oldest-old population are occurring worldwide. Countries including Japan, France, Italy and Germany are expected to have between 3 and 5% of their population aged 90 and over by 2050.

Cognition in the oldest-old: key questions

What is the prevalence of dementia in the oldest-old?

What are the causes of dementia in the oldest-old?

How can we screen for dementia in this population and what challenges must we overcome in the cognitive assessment of this age group?

What are the clinical–pathological correlates of dementia in the oldest-old?

The rapidly growing population over the age of 90 signals a need to understand aging and age-related conditions in the oldest-old. Many issues require investigation in these pioneers of aging. Estimates of dementia prevalence vary as described in more detail below.

References
,US Census Bureau. Census 2000 Summary File 2. Washington, DC: US Census Bureau, 2001.
,US Census Bureau. Population Projections (Middle Series). Washington, DC: US Census Bureau, 2002.
,United Nations Population Division. World Population Prospects: The 2004 Revision Population Database. New York: United Nations, 2005 http://esa.un.org/unpp.
Paganini-Hill, A, Ross, RK, Henderson, BE. Prevalence of chronic disease and health practices in a retirement community. J Chronic Dis. 1986;39:699–707.
Paganini-Hill, A, Chao, A, Ross, RK, Henderson, BE. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology. 1991;2:16–25.
Teng, EL, Chui, HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry. 1987;48:314–318.
Folstein, MF, Folstein, SE, McHugh, PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
Kaplan, EF, Goodglas, H, Weintraub, S. The Boston Naming Test. Boston, MA: Kaplan and Goodglass, 1978.
Mack, WJ, Freed, DM, Williams, BW, Henderson, VW. Boston Naming Test: shortened version for use in Alzheimer's disease. J Gerontol. 1992;47:164–168.
Benton, AL, Hamsher, K, Sivan, AB. Multilingual Aphasia Examination, 3rd edn. Iowa City, IA: AJA Associates, 1983.
Morris, JC, Mohs, R, Rogers, H, Fillenbaum, G, Heyman, A. Consortium to establish a registry for Alzheimer's disease (CERAD): clinical and neuropsychological assessment of Alzheimer's Disease. Psychopharmacol Bull. 1988;24:641–652.
Rouleau, I, Salmon, DP, Butters, N, Kennedy, C, McGuire, K. Quantitative and qualitative analyses of clock face drawings in Alzheimer's and Huntington's diseases. Brain Cogn. 1992;18:70–87.
Freedman, M, Kaplan, E, Delis, D, Morris, R. Clock Drawing: A Neuropsychological Analysis. New York: Oxford University Press, 1994.
Delis, DC, Kramer, JH, Kaplan, E, Ober, BA. California Verbal Learning Test, 2nd edn. San Antonio, TX: Psychological Corporation, 2000.
Wechsler, D. WAIS-III Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation and Harcourt Brace, 1997.
,US War Department. Army Individual Test Battery: Manual of Directions and Scoring. Washington, DC: War Department, Adjutant General's Office, 1944.
Reitan, RM, Wolfson, D. The Halstead–Reitan Neuropsychological Battery. Tucson, AZ: Neuropsychological Press, 1985.
Delis, D, Kaplan, E, Kramer, JH. The Delis–Kaplan Executive Function System (DK-EFS). San Antonio, TX: Psychological Corporation, 2001.
Ebly, EM, Parhad, IM, Hogan, DB, Fung, TS. Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology. 1994;44:1593–1600.
Riedel-Heller, SG, Busse, A, Aurich, C, Matschinger, H, Angermeyer, MC. Prevalence of dementia according to DSM-III-R and ICD-10: results of the Leipzig Longitudinal Study of the Aged (LEILA75+) Part 1. Br J Psychiatry. 2001;179:250–254.
Borjesson-Hanson, A, Edin, E, Gislason, T, Skoog, I. The prevalence of dementia in 95 year olds. Neurology. 2004;63:2436–2438.
Strauss, E, Viitanen, M, Ronchi, D, Winblad, B, Fratiglioni, L. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol. 1999;56:587–592.
Wernicke, TF, Reischies, FM. Prevalence of dementia in old age: Clinical diagnoses in subjects aged 95 years and older. Neurology. 1994;44:250–253.
Ott, A, Breteler, MM, Harskamp, F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310:970–973.
Heeren, TJ, Lagaay, AM, Hijmans, W, Rooymans, HG. Prevalence of dementia in the “oldest old” of a Dutch community. J Am Geriatr Soc. 1991;39:755–759.
Breitner, JC, Wyse, BW, Anthony, JC, et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology. 1999;53:321–331.
Ogura, C, Nakamoto, H, Uema, Tet al. Prevalence of senile dementia in Okinawa, Japan. COSEPO Group. Study Group of Epidemiology for Psychiatry in Okinawa. Int J Epidemiol. 1995;24:373–380.
O'Connor, DW, Pollitt, PA, Hyde, JB, et al. The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand. 1989;79:190–198.
Fratiglioni, L, Grut, M, Forsell, Y, et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology. 1991;41:1886–1892.
Ritchie, K, Kildea, D. Is senile dementia “age-related” or “ageing-related”? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995;346:931–934.
Jensen, GD, Polloi, AH. The very old of Palau: health and mental state. Age Ageing. 1988;17:220–226.
Asada, T, Yamagata, Z, Kinoshita, Tet al. Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan. J Am Geriatr Soc. 1996;44:151–155.
Ravaglia, G, Forti, P, Ronchi, Det al. Prevalence and severity of dementia among northern Italian centenarians. Neurology. 1999;53:416–418.
Blansjaar, BA, Thomassen, R, Schaick, HW. Prevalence of dementia in centenarians. Int J Geriatr Psychiatry. 2000;15:219–225.
Dewey, ME, Copeland, JR. Dementia in centenarians. Int J Geriatr Psychiatry. 2001;16:538–539.
O'Connor, DW, Pollitt, PA, Treasure, FP, Brook, CPB, Reiss, BB. The influence of education, social class, and sex on Mini-Mental State scores. Psychol Med. 1989;19:771–776.
Crum, RM, Anthony, JC, Bassett, SS, Folstein, MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386–2391.
Tombaugh, TN, McDowell, I, Kristjansson, B, Hubley, AM. Mini-Mental State Examination (MMSE) and the Modified MMSE (3MS): a psychometric comparison and normative data. Psychol Assess. 1996;8:48–59.
Iverson, G. Interpretation of Mini-Mental State Examination scores in community-dwelling elderly and geriatric neuropsychiatry patients. Int J Geriat Psychiatry. 1998;13:661–666.
Kahle-Wrobleski, K, Corrada, MM, Li, B, Kawas, CH. Sensitivity and specificity of the mini-mental state examination for identifying dementia in the oldest-old: the 90+ Study. J Am Geriatr Soc. 2007;55:284–289.
Heaton, RK, Grant, I, Matthews, C. Comprehensive Norms for an Expanded Halstead-Reitan Neuropsychological Battery: Demographic Corrections, Research Findings, and Clinical Applications. Odessa, FL: Psychological Assessment Resources, 1991.
Ivnik, RJ, Malec, JF, Smith, GE, Tangalos, EG, Petersen, RC. Neuropsychological tests' norms above age 55: COWAT, BNT, MAE Token, WRAT-R Reading, AMNART, STROOP, TMT, and JLO. Clin Neuropsychol. 1996;10:262–278.
Beeri, MS, Schmeidler, J, Sano, M, et al. Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old. Neurology. 2006;67:1006–1010.
Whittle, C, Corrada, MM, Dick, M, et al. Neuropsychological data in nondemented oldest-old: the 90+ Study. J Clin Exp Neuropsychol. 2007;29:290–299.
Kozora, E, Cullum, CM. Generative naming in normal aging: total output of qualitative changes using phonemic and semantic constraints. Clin Neuropsychol. 1995;9:313–320.
Fastenau, PS, Denburg, NL, Mauer, BA. Parallel short forms for the Boston Naming Test: psychometric properties and norms for older adults. J Clin Exp Neuropsychol. 1998;20:828–834.
Gorp, WG, Satz, P, Mitrashina, M. Neuropsychological processes associated with normal aging. Dev Neuropsychol. 1990;6:279–290.
Blennow, K, Leon, MJ, Zetterberg, H. Alzheimer's disease. Lancet. 2006;368:387–403.
Crystal, HA, Dickson, D, Davies, Pet al. The relative frequency of “dementia of unknown etiology” increases with age and is nearly 50% in nonagenarians. Arch Neurol. 2000;57:713–719.
Polvikoski, T, Sulkava, R, Myllykangas, Let al. Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology. 2001;56:1690–1696.
Katzman, R, Terry, RD, DeTeresa, Ret al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988;23:138–144.
Crystal, H, Dickson, D, Fuld, Pet al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 1988;38:1682–1687.
Corrada, MM, Head, E, Kim, R, Kawas, C. Braak and Braak staging and dementia in the oldest-old: preliminary results from the 90+ Study. In Proceedings of the 57th Annual American Academy of Neurology Meeting, April 9–16, 2005, Miami, FL.
Berlau, DJ, Kahle-Wrobleski, K, Head, EMG, Kim, R, Kawas, C.A case of dissociation between neuropathology and cognition in the oldest-old: a protective role of APOE-ϵ2. Arch Neurol. 2007;64:1193–1196.
,Alzheimer's Association. Alzheimer's Disease Facts and Figures. Chicago, IL: Alzheimer's Association, 2007.